1. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
- Author
-
Hjermstad, Marianne, Bergenmar, Mia, Bjordal, Kristin, Fisher, Sheila, Hofmeister, Dirk, Montel, Sébastien, Nicolatou-Galitis, Ourania, Pinto, Monica, Raber-Durlacher, Judith, Singer, Susanne, Tomaszewska, Iwona, Tomaszewski, Krzysztof, Verdonck-de Leeuw, Irma, Yarom, Noam, Winstanley, Julie, Herlofson, Bente, Hjermstad, Marianne J, Fisher, Sheila E, Montel, Sébastien, and Tomaszewska, Iwona M
- Subjects
ORAL medicine ,QUALITY of life ,PSYCHOMETRICS ,CANCER patient care ,PATIENT satisfaction ,MENTAL health ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,ORAL hygiene ,PSYCHOLOGICAL tests ,QUESTIONNAIRES ,RESEARCH ,EVALUATION research - Abstract
Purpose: This international EORTC validation study (phase IV) is aimed at testing the psychometric properties of a quality of life (QoL) module related to oral health problems in cancer patients.Methods: The phase III module comprised 17 items with four hypothesized multi-item scales and three single items. In phase IV, patients with mixed cancers, in different treatment phases from 10 countries completed the EORTC QLQ-C30, the QLQ-OH module, and a debriefing interview. The hypothesized structure was tested using combinations of classical test theory and item response theory, following EORTC guidelines. Test-retest assessments and responsiveness to change analysis (RCA) were performed after 2 weeks.Results: Five hundred seventy-two patients (median age 60.3, 54 % females) were analyzed. Completion took <10 min for 84 %, 40 % expressed satisfaction that these issues were addressed. Analyses suggested a revision of the phase III hypothesized scale structure. Two items were deleted based on a high degree of item misfit, together with negative patient feedback. The remaining 15 items formed one eight-item scale named OH-QoL score, a two-item information scale, a two-item scale regarding dentures, and three single items (sticky saliva/mouth soreness/sensitivity to food/drink). Face and convergent validity and internal consistency were confirmed. Test-retest reliability (n = 60) was demonstrated as was RCA for patients undergoing chemotherapy (n = 117; p = 0.06). The resulting QLQ-OH15 discriminated between clinically distinct patient groups, e.g., low performance status vs. higher (p < 000.1), and head-and-neck cancer versus other cancers (p < 0.03).Conclusion: The EORTC module QLQ-OH15 is a short, well-accepted assessment tool focusing on oral problems and QoL to improve clinical management.Trial Registration: ClinicalTrials.gov Identifier: NCT01724333. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF